NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Acne vulgaris
Date of first enrollment	01/4/2010
Target sample size
Countries of recruitment
Study type	INTERVENTIONAL
Intervention(s)	Intervention name : M512101 Dosage And administration of the intervention : Proper quantity once a day or twice a day Control intervention name : M512101 placebo Dosage And administration of the control intervention : Proper quantity once a day or twice a day

Outcome(s)

Primary Outcome	The percent reduction in inflammatory lesion counts.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	13
Age maximum	49
Gender	BOTH
Include criteria	1. Patients diagnosed with acne vulgaris 2. Outpatient
Exclude criteria